↓ Skip to main content

Dove Medical Press

Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
36 Mendeley
Title
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Published in
Therapeutics and Clinical Risk Management, January 2019
DOI 10.2147/tcrm.s160248
Pubmed ID
Authors

Teng Moua, Jay H Ryu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 28%
Student > Ph. D. Student 4 11%
Student > Master 3 8%
Researcher 2 6%
Professor > Associate Professor 2 6%
Other 3 8%
Unknown 12 33%
Readers by discipline Count As %
Medicine and Dentistry 11 31%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Engineering 2 6%
Agricultural and Biological Sciences 1 3%
Other 4 11%
Unknown 14 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2019.
All research outputs
#15,175,718
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#667
of 1,323 outputs
Outputs of similar age
#234,237
of 446,429 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 20 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,429 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.